<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39339437</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>19</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Synthesis, Characterization, and Biological Evaluation of <i>N</i>-Methyl Derivatives of Norbelladine.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4442</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules29184442</ELocationID><Abstract><AbstractText>Norbelladine derivatives have garnered attention in recent years due to their diverse biological activities and pivotal role in the biosynthetic pathway of Amaryllidaceae alkaloids. This study reports the synthesis and biological evaluation of four O,<i>N</i>-methylated derivatives of norbelladine. These derivatives were synthesized through a three-step process: forming imine intermediates from benzaldehydes with tyramine, hydrogenating them to secondary amines, and <i>N</i>-methylating these amines. The products were purified and characterized by <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy. Their biological activities were assessed by evaluating their ability to inhibit Alzheimer's disease-related enzymes acetylcholinesterase and butyrylcholinesterase. Additionally, the cytotoxic activity of the novel derivatives was tested against cancer cell lines derived from hepatocarcinoma (Huh7), adenocarcinoma (HCT-8), and acute myeloid leukemia (THP-1) cells, and their antiviral properties against a human coronavirus (HCoV-OC43), a flavivirus (dengue virus), and a lentivirus (pseudotyped HIV-1). Docking analysis was performed to understand the impact of the <i>N</i>-methylation on their pharmacological relevance. The results indicate that while <i>N</i>-methylation does not significantly affect antiviral activity, it enhances butyrylcholinesterase inhibition for <i>N</i>-methylnorbelladine and 4'-<i>O</i>,<i>N</i>-dimethylnorbelladine. Overall, this work enhances our understanding of norbelladine derivatives, provides new tools for Alzheimer's disease research, and lays the groundwork for future pharmaceutical developments.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hashemian</LastName><ForeName>S Mahsa</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Biochemistry and Physics, Université du Québec à Trois-Rivières, Trois-Rivières, QC G8Z 4M3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merindol</LastName><ForeName>Natacha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Biochemistry and Physics, Université du Québec à Trois-Rivières, Trois-Rivières, QC G8Z 4M3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paquin</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Université du Québec à Montréal, Montréal, QC H2L 2C4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Amita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Biology, Université du Québec à Trois-Rivières, Trois-Rivières, QC G8Z 4M3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berthoux</LastName><ForeName>Lionel</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Biology, Université du Québec à Trois-Rivières, Trois-Rivières, QC G8Z 4M3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daoust</LastName><ForeName>Benoit</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-6486-3647</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Biochemistry and Physics, Université du Québec à Trois-Rivières, Trois-Rivières, QC G8Z 4M3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desgagné-Penix</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-4355-5503</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Biochemistry and Physics, Université du Québec à Trois-Rivières, Trois-Rivières, QC G8Z 4M3, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Plant Biology Research Group, Trois-Rivières, QC G8Z 4M3, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RGPIN-2021-03218</GrantID><Agency>Natural Sciences and Engineering Research Council of Canada</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.1.8</RegistryNumber><NameOfSubstance UI="D002091">Butyrylcholinesterase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.1.7</RegistryNumber><NameOfSubstance UI="D000110">Acetylcholinesterase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002800">Cholinesterase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="Y">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="Y">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002091" MajorTopicYN="Y">Butyrylcholinesterase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000110" MajorTopicYN="N">Acetylcholinesterase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002800" MajorTopicYN="N">Cholinesterase Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008745" MajorTopicYN="N">Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amaryllidaceae alkaloids</Keyword><Keyword MajorTopicYN="N">RNA virus</Keyword><Keyword MajorTopicYN="N">acetylcholinesterase</Keyword><Keyword MajorTopicYN="N">butyrylcholinesterase</Keyword><Keyword MajorTopicYN="N">molecular docking</Keyword><Keyword MajorTopicYN="N">tertiary amines</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39339437</ArticleId><ArticleId IdType="pmc">PMC11433679</ArticleId><ArticleId IdType="doi">10.3390/molecules29184442</ArticleId><ArticleId IdType="pii">molecules29184442</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jin Z., Xu X.-H. Amaryllidaceae Alkaloids. In: Ramawat K.G., Mérillon J.-M., editors. Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes. Springer; Berlin/Heidelberg, Germany: 2013. pp. 479–522.</Citation></Reference><Reference><Citation>Hotchandani T., Desgagne-Penix I. Heterocyclic Amaryllidaceae Alkaloids: Biosynthesis and Pharmacological Applications. Curr. Top. Med. Chem. 2017;17:418–427. doi: 10.2174/1568026616666160824104052.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026616666160824104052</ArticleId><ArticleId IdType="pubmed">27558679</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgagné-Penix I. Biosynthesis of alkaloids in Amaryllidaceae plants: A review. Phytochem. Rev. 2021;20:409–431. doi: 10.1007/s11101-020-09678-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11101-020-09678-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayawardena T.U., Merindol N., Liyanage N.S., Desgagné-Penix I. Unveiling Amaryllidaceae alkaloids: From biosynthesis to antiviral potential—A review. Nat. Prod. Rep. 2024;41:721–747. doi: 10.1039/D3NP00044C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D3NP00044C</ArticleId><ArticleId IdType="pubmed">38131392</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A., Massicotte M.-A., Garand A., Tousignant L., Ouellette V., Bérubé G., Desgagné-Penix I. Cloning and characterization of norbelladine synthase catalyzing the first committed reaction in Amaryllidaceae alkaloid biosynthesis. BMC Plant Biol. 2018;18:338. doi: 10.1186/s12870-018-1570-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12870-018-1570-4</ArticleId><ArticleId IdType="pmc">PMC6286614</ArticleId><ArticleId IdType="pubmed">30526483</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichman B.R. The scaffold-forming steps of plant alkaloid biosynthesis. Nat. Prod. Rep. 2021;38:103–129. doi: 10.1039/D0NP00031K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D0NP00031K</ArticleId><ArticleId IdType="pubmed">32745157</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinrich M., Lee Teoh H. Galanthamine from snowdrop—The development of a modern drug against Alzheimer’s disease from local Caucasian knowledge. J. Ethnopharmacol. 2004;92:147–162. doi: 10.1016/j.jep.2004.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2004.02.012</ArticleId><ArticleId IdType="pubmed">15137996</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartolucci C., Perola E., Pilger C., Fels G., Lamba D. Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: Implications for the design of new anti-Alzheimer drugs. Proteins. 2001;42:182–191. doi: 10.1002/1097-0134(20010201)42:2&lt;182::AID-PROT50&gt;3.0.CO;2-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-0134(20010201)42:2&lt;182::AID-PROT50&gt;3.0.CO;2-1</ArticleId><ArticleId IdType="pubmed">11119642</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J., Lee G., Zhong K., Fonseca J., Taghva K. Alzheimer’s disease drug development pipeline: 2021. Alzheimer’s Dement. 2021;7:e12179. doi: 10.1002/trc2.12179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12179</ArticleId><ArticleId IdType="pmc">PMC8145448</ArticleId><ArticleId IdType="pubmed">34095440</ArticleId></ArticleIdList></Reference><Reference><Citation>Evidente A., Kireev A.S., Jenkins A.R., Romero A.E., Steelant W.F., Van Slambrouck S., Kornienko A. Biological evaluation of structurally diverse amaryllidaceae alkaloids and their synthetic derivatives: Discovery of novel leads for anticancer drug design. Planta Med. 2009;75:501–507. doi: 10.1055/s-0029-1185340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0029-1185340</ArticleId><ArticleId IdType="pmc">PMC3125136</ArticleId><ArticleId IdType="pubmed">19235683</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino S., Meyer M., Zorbas C., Bouchta S.A., Saraf K., Pelly S.C., Yusupova G., Evidente A., Mathieu V., Kornienko A., et al. The Amaryllidaceae Alkaloid Haemanthamine Binds the Eukaryotic Ribosome to Repress Cancer Cell Growth. Structure. 2018;26:416–425.e4. doi: 10.1016/j.str.2018.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2018.01.009</ArticleId><ArticleId IdType="pubmed">29429877</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrielsen B., Monath T.P., Huggins J.W., Kefauver D.F., Pettit G.R., Groszek G., Hollingshead M., Kirsi J.J., Shannon W.M., Schubert E.M., et al. Antiviral (RNA) activity of selected Amaryllidaceae isoquinoline constituents and synthesis of related substances. J. Nat. Prod. 1992;55:1569–1581. doi: 10.1021/np50089a003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/np50089a003</ArticleId><ArticleId IdType="pubmed">1336040</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Li L.F., Wang Q.Y., Shang L.Q., Shi P.Y., Yin Z. Anti-dengue-virus activity and structure-activity relationship studies of lycorine derivatives. ChemMedChem. 2014;9:1522–1533. doi: 10.1002/cmdc.201300505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.201300505</ArticleId><ArticleId IdType="pmc">PMC7162318</ArticleId><ArticleId IdType="pubmed">24574246</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.N., Zhang Q.Y., Li X.D., Xiong J., Xiao S.Q., Wang Z., Zhang Z.R., Deng C.L., Yang X.L., Wei H.P., et al. Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture. Emerg. Microbes Infect. 2020;9:1170–1173. doi: 10.1080/22221751.2020.1772676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1772676</ArticleId><ArticleId IdType="pmc">PMC7448857</ArticleId><ArticleId IdType="pubmed">32432977</ArticleId></ArticleIdList></Reference><Reference><Citation>Ka S., Merindol N., Sow A.A., Singh A., Landelouci K., Plourde M.B., Pepin G., Masi M., Di Lecce R., Evidente A., et al. Amaryllidaceae Alkaloid Cherylline Inhibits the Replication of Dengue and Zika Viruses. Antimicrob. Agents Chemother. 2021;65:e0039821. doi: 10.1128/AAC.00398-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00398-21</ArticleId><ArticleId IdType="pmc">PMC8370201</ArticleId><ArticleId IdType="pubmed">34152811</ArticleId></ArticleIdList></Reference><Reference><Citation>Masi M., Di Lecce R., Merindol N., Girard M.P., Berthoux L., Desgagne-Penix I., Calabro V., Evidente A. Cytotoxicity and Antiviral Properties of Alkaloids Isolated from Pancratium maritimum. Toxins. 2022;14:262. doi: 10.3390/toxins14040262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins14040262</ArticleId><ArticleId IdType="pmc">PMC9029599</ArticleId><ArticleId IdType="pubmed">35448871</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard M.-P., Merindol N., Berthoux L., Desgagné-Penix I. Le pouvoir antiviral des alcaloïdes de végétaux contre les virus à ARN. Virologie. 2022;26:431–450. doi: 10.1684/vir.2022.0979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1684/vir.2022.0979</ArticleId><ArticleId IdType="pubmed">36565261</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard M.P., Karimzadegan V., Heneault M., Cloutier F., Berube G., Berthoux L., Merindol N., Desgagne-Penix I. Chemical Synthesis and Biological Activities of Amaryllidaceae Alkaloid Norbelladine Derivatives and Precursors. Molecules. 2022;27:5621. doi: 10.3390/molecules27175621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27175621</ArticleId><ArticleId IdType="pmc">PMC9457815</ArticleId><ArticleId IdType="pubmed">36080382</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaněčková N., Hošt‘álková A., Šafratová M., Kuneš J., Hulcová D., Hrabinová M., Doskočil I., Štěpánková Š., Opletal L., Nováková L., et al. Isolation of Amaryllidaceae alkaloids from Nerine bowdenii W. Watson and their biological activities. RSC Adv. 2016;6:80114–80120. doi: 10.1039/C6RA20205E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6RA20205E</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Mamun A., Maříková J., Hulcová D., Janoušek J., Šafratová M., Nováková L., Kučera T., Hrabinová M., Kuneš J., Korábečný J., et al. Amaryllidaceae Alkaloids of Belladine-Type from Narcissus pseudonarcissus cv. Carlton as New Selective Inhibitors of Butyrylcholinesterase. Biomolecules. 2020;10:800. doi: 10.3390/biom10050800.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10050800</ArticleId><ArticleId IdType="pmc">PMC7277649</ArticleId><ArticleId IdType="pubmed">32455879</ArticleId></ArticleIdList></Reference><Reference><Citation>Hostalkova A., Marikova J., Opletal L., Korabecny J., Hulcova D., Kunes J., Novakova L., Perez D.I., Jun D., Kucera T., et al. Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer’s Disease. J. Nat. Prod. 2019;82:239–248. doi: 10.1021/acs.jnatprod.8b00592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jnatprod.8b00592</ArticleId><ArticleId IdType="pubmed">30701972</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachon F., Carletti E., Ronco C., Trovaslet M., Nicolet Y., Jean L., Renard P.Y. Crystal structures of human cholinesterases in complex with huprine W and tacrine: Elements of specificity for anti-Alzheimer’s drugs targeting acetyl- and butyryl-cholinesterase. Biochem. J. 2013;453:393–399. doi: 10.1042/BJ20130013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20130013</ArticleId><ArticleId IdType="pubmed">23679855</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.B. Synthesis and characterization of norbelladine, a precursor of Amaryllidaceae alkaloid, as an anti-inflammatory/anti-COX compound. Bioorg. Med. Chem. Lett. 2014;24:5381–5384. doi: 10.1016/j.bmcl.2014.10.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2014.10.051</ArticleId><ArticleId IdType="pubmed">25453792</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamun A.A., Pidany F., Hulcova D., Marikova J., Kucera T., Schmidt M., Catapano M.C., Hrabinova M., Jun D., Muckova L., et al. Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking Studies. Int. J. Mol. Sci. 2021;22:8308. doi: 10.3390/ijms22158308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22158308</ArticleId><ArticleId IdType="pmc">PMC8348983</ArticleId><ArticleId IdType="pubmed">34361074</ArticleId></ArticleIdList></Reference><Reference><Citation>Darvesh S., Hopkins D.A., Geula C. Neurobiology of butyrylcholinesterase. Nat. Rev. Neurosci. 2003;4:131–138. doi: 10.1038/nrn1035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1035</ArticleId><ArticleId IdType="pubmed">12563284</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Li A.J., Travers J., Xu T., Sakamuru S., Klumpp-Thomas C., Huang R., Xia M. Identification of Compounds for Butyrylcholinesterase Inhibition. SLAS Discov. Adv. Sci. Drug Discov. 2021;26:1355–1364. doi: 10.1177/24725552211030897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/24725552211030897</ArticleId><ArticleId IdType="pmc">PMC8637366</ArticleId><ArticleId IdType="pubmed">34269114</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanzari-Mnallah D., Salhi S., Knorr M., Kirchhoff J.-L., Strohmann C., Efrit M.L., Akacha A.B. Synthesis of isomeric β-cycloalkoxyphosphonated hydrazones containing a dioxaphosphorinane ring: Configurational and conformational investigation and molecular docking analysis. J. Mol. Struct. 2024;1317:139035. doi: 10.1016/j.molstruc.2024.139035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molstruc.2024.139035</ArticleId></ArticleIdList></Reference><Reference><Citation>Padilla-Bernal G., Vargas R., Martínez A. Salt bridge: Key interaction between antipsychotics and receptors. Theor. Chem. Acc. 2023;142:65. doi: 10.1007/s00214-023-03016-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00214-023-03016-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedli M.J., Inestrosa N.C. Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease. Molecules. 2021;26:6531. doi: 10.3390/molecules26216531.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26216531</ArticleId><ArticleId IdType="pmc">PMC8587556</ArticleId><ArticleId IdType="pubmed">34770940</ArticleId></ArticleIdList></Reference><Reference><Citation>Armarego W.L. Purification of Laboratory Chemicals: Part 2 Inorganic Chemicals, Catalysts, Biochemicals, Physiologically Active Chemicals, Nanomaterials. Butterworth-Heinemann; Oxford, UK: 2022.</Citation></Reference><Reference><Citation>Zippilli C., Botta L., Bizzarri B.M., Nencioni L., De Angelis M., Protto V., Giorgi G., Baratto M.C., Pogni R., Saladino R. Laccase-Catalyzed 1,4-Dioxane-Mediated Synthesis of Belladine N-Oxides with Anti-Influenza A Virus Activity. Int. J. Mol. Sci. 2021;22:1337. doi: 10.3390/ijms22031337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22031337</ArticleId><ArticleId IdType="pmc">PMC7866262</ArticleId><ArticleId IdType="pubmed">33572794</ArticleId></ArticleIdList></Reference><Reference><Citation>Salentin S., Schreiber S., Haupt V.J., Adasme M.F., Schroeder M. PLIP: Fully automated protein-ligand interaction profiler. Nucleic Acids Res. 2015;43:W443–W447. doi: 10.1093/nar/gkv315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv315</ArticleId><ArticleId IdType="pmc">PMC4489249</ArticleId><ArticleId IdType="pubmed">25873628</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl W., Bartenschlager R. High-throughput screening using dengue virus reporter genomes. Methods Mol. Biol. 2013;1030:205–219. doi: 10.1007/978-1-62703-484-5_17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-62703-484-5_17</ArticleId><ArticleId IdType="pubmed">23821271</ArticleId></ArticleIdList></Reference><Reference><Citation>He J., Chen Y., Farzan M., Choe H., Ohagen A., Gartner S., Busciglio J., Yang X., Hofmann W., Newman W., et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature. 1997;385:645–649. doi: 10.1038/385645a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/385645a0</ArticleId><ArticleId IdType="pubmed">9024664</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatel-Chaix L., Bartenschlager R. Dengue virus- and hepatitis C virus-induced replication and assembly compartments: The enemy inside—Caught in the web. J. Virol. 2014;88:5907–5911. doi: 10.1128/JVI.03404-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03404-13</ArticleId><ArticleId IdType="pmc">PMC4093888</ArticleId><ArticleId IdType="pubmed">24623440</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>